Key result
Medication management in patients with ESKD on dialysis requires strategies such as medication reconciliation, review, deprescribing, and consideration of social determinants of health.
Why the study?
Complicated regimens in patients with ESKD on chronic dialysis put them at high risk for medication therapy problems related to safety, effectiveness, appropriateness, and adherence.
This review highlights the complexities of medication management in dialysis patients and recommends strategies such as medication reconciliation, deprescribing, and addressing social determinants of health to improve safety and adherence.
Complex regimens heighten medication therapy problem risks in dialysis patients; leaves open optimal management strategies.
People with end-stage kidney disease (ESKD) who require chronic dialysis are often reliant on complicated medication regimens to manage their health conditions. Due to the complexities of the advanced kidney disease, underlying comorbidities, and special instructions, medication regimens for patients on dialysis put patients at high risk for medication therapy problems related to safety, effectiveness, appropriateness, and adherence. This article explores the factors that affect optimal medication use for people on dialysis, including the broader drug use system, and offers recommendations around medication reconciliation, medication review, deprescribing, and considering social determinants of health to improve medication management among patients with ESKD.
No takes yet. Share an insight, caveat, or question.
Cardone et al. (2020) conducted a review in End-stage kidney disease (ESKD) requiring chronic dialysis. Medication management strategies was evaluated. Medication management in patients with ESKD on dialysis requires strategies such as medication reconciliation, review, deprescribing, and consideration of social determinants of health.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: